Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 26,000 shares at $40.01 ($1.0M) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Scheduled sale ($1.0M) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARCT | SELL | 2024-03-27 | $1.2M | — | Filing → |
| ARCT | SELL | 2024-03-21 | $600K | — | Filing → |
| ARCT | SELL | 2023-11-03 | $94K | — | Filing → |